EMU 116
Alternative Names: EMU-116Latest Information Update: 07 Jun 2022
Price :
$50 *
At a glance
- Originator Junrui Biotechnology
- Class Antineoplastics; Small molecules; Tetrahydroisoquinolines
- Mechanism of Action CXCR4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Urogenital cancer